Natural Pharmaceuticals Shared Service OÜ
Natural Pharmaceuticals Shared Service OÜ is a OÜ based in Valga linn, registry code 14794771, status: active. Main activity: Activities of call centres. According to EMTA, turnover for Q3 2026 was €144 427 with 22 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 144 427 €above 87% of companiesindustry median 14 685 € · companies in the industry: 1 227
- Labour taxes per employee 1 214 €above 43% of companiesindustry median 1 350 € · companies in the industry: 777
- Revenue · 2025 483 129 €above 98% of companiesindustry median 3 483 € · companies in the industry: 3 688
- Net profit margin · 2025 1.3 %above 32% of companiesindustry median 11.2 % · companies in the industry: 2 113
Taxes and turnover
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 144 427 | 25 261 | 26 708 | 22 |
| Q2 2026 | 140 451 | 31 932 | 24 628 | 16 |
| Q1 2026 | 157 686 | 24 409 | 25 687 | 19 |
| Q4 2025 | 166 945 | 28 967 | 30 517 | 20 |
| Q3 2025 | 137 441 | 29 297 | 30 840 | 21 |
| Q2 2025 | 126 684 | 26 399 | 27 865 | 20 |
| Q1 2025 | 129 568 | 25 006 | 26 426 | 18 |
| Q4 2024 | 145 731 | 25 750 | 27 312 | 21 |
| Q3 2024 | 126 940 | 25 312 | 26 850 | 22 |
| Q2 2024 | 139 425 | 23 430 | 24 847 | 20 |
| Q1 2024 | 154 844 | 25 975 | 27 332 | 18 |
| Q4 2023 | 144 002 | 25 105 | 26 681 | 19 |
| Q3 2023 | 116 193 | 29 657 | 31 269 | 24 |
| Q2 2023 | 127 853 | 26 617 | 28 222 | 21 |
| Q1 2023 | 136 538 | 24 165 | 25 552 | 25 |
| Q4 2022 | 133 696 | 26 728 | 27 794 | 23 |
| Q3 2022 | 137 699 | 32 917 | 34 915 | 22 |
| Q2 2022 | 142 189 | 30 708 | 32 664 | 25 |
| Q1 2022 | 132 892 | 28 837 | 30 529 | 25 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Office administrative, office support and other business support activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 483 129 | 6 076 | 325 989 | 125 866 | 72 389 | 20 |
| 2024 | 460 527 | 7 464 | 311 917 | 128 290 | 66 313 | 22 |
| 2023 | 462 348 | 6 294 | 333 804 | 112 380 | 58 849 | 22 |
| 2022 | 478 870 | 6 278 | 342 301 | 106 164 | 52 555 | 25 |
| 2021 | 454 902 | 21 997 | 323 367 | 114 510 | 46 277 | 24 |
| 2020 | 390 723 | 21 780 | 263 720 | 83 093 | 24 280 | 21 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 24 Feb 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 28 Feb 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 1 Mar 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 27 Feb 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 28 Feb 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 2 Sep 2019 – 31 Dec 2020 | 12 Mar 2021 | Company’s own · audited | e-Äriregister |
Board
- Carl Jonas TörnquistBoard member · since 14 Nov 2019
- Andrius ButkevičiusBoard member · since 1 Oct 2025
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Natural Pharmaceuticals Sp. z.o.o.Legal person · 2 500 €
Beneficial owners
- Knut-Erik Langtvedt KarlsenIndirect ownership · NOR · since 7 Oct 2019
Founders and other persons
- Natural Pharmaceuticals Sp. z.o.o.Founder · 2 500 € · 29 Aug 2019
- Audiitorteenuse OÜAudit firm · 8 Oct 2021
Activities (EMTAK)
- 82201Activities of call centres Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50127107 / 10 1 Oct 2025 |
Amendment entry | In force 1 Oct 2025 |
||
| Ä 50127107 / M3 5 Oct 2023 |
Ruling to eliminate deficiencies | Deficiencies eliminated 5 Oct 2023 |
||
| Ä 50127107 / 9 5 Oct 2023 |
Amendment under Code of Civil Procedure § 595¹ (1) | In force 5 Oct 2023 |
||
| Ä 50127107 / 8 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50127107 / 7 27 Jul 2023 |
Amendment entry | In force 27 Jul 2023 |
||
| Ä 50127107 / 6 17 May 2023 |
Amendment entry | In force 17 May 2023 |
||
| Ä 50127107 / 5 20 Jan 2020 |
Entry refused: deficiencies not eliminated | In force 6 Feb 2020 |
||
| Ä 50127107 / M2 14 Nov 2019 |
Ruling to eliminate deficiencies | 14 Dec 2019 | In force 14 Nov 2019 |
|
| Ä 50127107 / 4 14 Nov 2019 |
Amendment entry | In force 14 Nov 2019 |
||
| Ä 50127107 / 3 17 Oct 2019 |
Amendment entry | In force 17 Oct 2019 |
||
| Ä 50127107 / 2 3 Sep 2019 |
Amendment entry | In force 3 Sep 2019 |
||
| Ä 50127107 2 Sep 2019 |
First entry | In force 2 Sep 2019 |
||
| Ä 50127107 / M1 30 Aug 2019 |
Procedural ruling | In force 30 Aug 2019 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data